AptaBio Therapeutics (Korea) Market Value
| 293780 Stock | 6,590 310.00 4.94% |
| Symbol | AptaBio |
AptaBio Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to AptaBio Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of AptaBio Therapeutics.
| 07/05/2023 |
| 11/26/2024 |
If you would invest 0.00 in AptaBio Therapeutics on July 5, 2023 and sell it all today you would earn a total of 0.00 from holding AptaBio Therapeutics or generate 0.0% return on investment in AptaBio Therapeutics over 510 days. AptaBio Therapeutics is related to or competes with Genolution. More
AptaBio Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure AptaBio Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess AptaBio Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.13) | |||
| Maximum Drawdown | 19.84 | |||
| Value At Risk | (7.02) | |||
| Potential Upside | 6.16 |
AptaBio Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for AptaBio Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as AptaBio Therapeutics' standard deviation. In reality, there are many statistical measures that can use AptaBio Therapeutics historical prices to predict the future AptaBio Therapeutics' volatility.| Risk Adjusted Performance | (0.07) | |||
| Jensen Alpha | (0.35) | |||
| Total Risk Alpha | (1.07) | |||
| Treynor Ratio | 0.715 |
AptaBio Therapeutics Backtested Returns
AptaBio Therapeutics secures Sharpe Ratio (or Efficiency) of -0.0891, which signifies that the company had a -0.0891% return per unit of risk over the last 3 months. AptaBio Therapeutics exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm AptaBio Therapeutics' Standard Deviation of 4.15, mean deviation of 3.11, and Risk Adjusted Performance of (0.07) to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of -0.59, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning AptaBio Therapeutics are expected to decrease at a much lower rate. During the bear market, AptaBio Therapeutics is likely to outperform the market. At this point, AptaBio Therapeutics has a negative expected return of -0.37%. Please make sure to confirm AptaBio Therapeutics' total risk alpha, maximum drawdown, potential upside, as well as the relationship between the treynor ratio and value at risk , to decide if AptaBio Therapeutics performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.41 |
Modest reverse predictability
AptaBio Therapeutics has modest reverse predictability. Overlapping area represents the amount of predictability between AptaBio Therapeutics time series from 5th of July 2023 to 16th of March 2024 and 16th of March 2024 to 26th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of AptaBio Therapeutics price movement. The serial correlation of -0.41 indicates that just about 41.0% of current AptaBio Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.41 | |
| Spearman Rank Test | -0.39 | |
| Residual Average | 0.0 | |
| Price Variance | 4.8 M |
AptaBio Therapeutics lagged returns against current returns
Autocorrelation, which is AptaBio Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting AptaBio Therapeutics' stock expected returns. We can calculate the autocorrelation of AptaBio Therapeutics returns to help us make a trade decision. For example, suppose you find that AptaBio Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
AptaBio Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If AptaBio Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if AptaBio Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in AptaBio Therapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
AptaBio Therapeutics Lagged Returns
When evaluating AptaBio Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of AptaBio Therapeutics stock have on its future price. AptaBio Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, AptaBio Therapeutics autocorrelation shows the relationship between AptaBio Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in AptaBio Therapeutics.
Regressed Prices |
| Timeline |
Pair Trading with AptaBio Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if AptaBio Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AptaBio Therapeutics will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to AptaBio Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace AptaBio Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back AptaBio Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling AptaBio Therapeutics to buy it.
The correlation of AptaBio Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as AptaBio Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if AptaBio Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for AptaBio Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in AptaBio Stock
AptaBio Therapeutics financial ratios help investors to determine whether AptaBio Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in AptaBio with respect to the benefits of owning AptaBio Therapeutics security.